Utilidad de la espirometría en los pacientes hospitalizados por la enfermedad pulmonar obstructiva crónica (EPOC) exacerbada

Alfredo Hernández-Ruiz; Héctor José Ortega; Daniel Camilo Aguirre-Acevedo

doi:10.17533/udea.iatreia.59

Authors

Alfredo Hernández-Ruiz Somer Clinic https://orcid.org/0000-0003-2359-0931
Héctor José Ortega CardioVid Clinic
Daniel Camilo Aguirre-Acevedo University of Antioquia https://orcid.org/0000-0001-8728-0911

DOI:

https://doi.org/10.17533/udea.iatreia.59

Keywords:

pulmonary disease, chronic obstructive, spirometry, recurrence, hospitalization

Abstract

Spirometry is the standard test to confirm the diagnosis of Chronic Obstructive Pulmonary Disease (COPD). In hospitalization services it is common to find patients admitted with suspicion of this condition during an exacerbation. Based on current guidelines, there is controversy about use or not spirometry in this setting.

Objective: To review the diagnostic utility of spirometry in hospitalized patients with suspected exacerbated OPD.

Development: A non-systematic review was carried out until November 2019. The databases consulted were PubMed, Cochrane, EMBASE, LILACS, Google Scholar. Prospective studies were included, in patients over 18 years of age, in English and Spanish. Were found 573 articles and 20 relevant articles were selected for discussion.

Conclusions: In hospitalized patients with suspected exacerbated COPD, spirometry is a useful tool to confirm the diagnosis. The time to perform it would be prior to discharge, once the patient is stable. Of note, FEV1 would not be useful for establishing severity.

|Abstract

= 740 veces | PDF (ESPAÑOL (ESPAÑA))

= 469 veces| | HTML (ESPAÑOL (ESPAÑA))

= 15 veces|

Downloads

Download data is not yet available.

Author Biographies

Alfredo Hernández-Ruiz, Somer Clinic

MD, specialist in Internal Medicine. MSc in Clinical Epidemiology. Research Unit Director Somer Clinic, Rionegro.

Héctor José Ortega, CardioVid Clinic

MD, Specialist in Pneumology.

Daniel Camilo Aguirre-Acevedo, University of Antioquia

PhD and MSc in Epidemiology and Statistics, Academic Group of Clinical Epidemiology. Medical Research Institute.

References

(1) López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. DOI 10.1111/resp.12660.

(2) COPD. Global strategy for the diagnosis, management, and prevention the crhonic ostructive pulmonary disease (repot 2019) [internet]. [Consultado el 2019/08/01]. Disponible en: https://bit.ly/2IxY2nb

(3) Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–68. DOI 10.1183/09031936.05.00035205.

(4) Yu WC, Fu SN, Tai EL-B, Yeung YC, Kwong KC, Chang Y et al. Spirometry is underused in the diagnosis and monitoring of patients with chronic obstructive pulmonary disease (COPD). Int J Chron Obstruct Pulmon Dis. 2013;8:389-95. DOI 10.2147/COPD.S48659.

(5) Ancochea J, Miravitlles M, García-Río F, Muñoz L, Sánchez G, Sobradillo V et al. Infradiagnóstico de la enfermedad pulmonar obstructiva crónica en mujeres: Cuantificación del problema, determinantes y propuestas de acción. Arch Bronconeumol. 2013;49(6):223-9. DOI: 10.1016/j.arbres.2012.11.010.

(6) Pellicer Císcar C, Soler Cataluña JJ, Andreu Rodríguez AL, Bueso Fabra J. Diagnosis of COPD in hospitalised patients. Arch Bronconeumol. 2010;46(2):64-9. DOI 10.1016/S1579-2129(10)70017-3.

(7) Wu H, Wise RA, Medinger AE. Do Patients Hospitalized With COPD Have Airflow Obstruction? Chest. 2017;151(6):1263-71. DOI 10.1016/j.chest.2017.01.003.

(8) Wróblewska I, Olesniewicz P, Kurpas D, Sołtysik M, Błaszczuk J. Analysis of spirometry results in hospitalized patients aged over 65 years. Clin Interv Aging. 2015;10:1071–6. DOI 10.2147/CIA.S85387.

(9) Prieto Centurion V, Huang F, Naureckas ET, Camargo Ca, Charbeneau J, Joo MJ et al. Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation. BMC Pulm Med. 2012;12(1):73. DOI 10.1186/1471-2466-12-73.

(10) O’Donnell DE, Parker CM. COPD exacerbations. 3: Pathophysiology. Thorax. 2006;61(4):354-61. DOI 10.1136/thx.2005.041830.

(11) Global strategy for the diagnosis, management and prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD), (2015) [internet]. [Consultado el 2019/08/01] Disponible en: https://www.mscbs.gob.es/organizacion/sns/planCalidadSNS/pdf/GOLD_Report_2015_Apr2.pdf

(12) National Institute for Health and Care Excellence. Chronic obstructiv obstructive e pulmonary disease in over 16s: diagnosis and management. NICE Clinical guideline [internet]. [Consultado 2018/10/10]. Disponible en: https://www.nice.org.uk/guidance/cg101

(13) Driscoll BRO, Howard LS, Earis J, Mak V. British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017;4(1). DOI 10.1136/bmjresp-2016-000170.

(14) CINETS. Guía de práctica clínica basada en la evidencia para la prevención, diagnóstico, tratamiento y seguimiento de la enfermedad pulmonar obstructiva crónica (EPOC) en población adulta [internet]. [Consultado el 2018/05/01]. Disponible en: https://bit.ly/337S4mG

(15) Miravitlles M, Soler-cataluña JJ, Calle M, Molina J, Almagro P, Antonio J et al. Guía española de la EPOC (GesEPOC ). Actualización 2014. Arch Bronconeumol. 2014;50(Supl 1):1-16. DOI 10.1016/S0300-2896(14)70070-5.

(16) Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2000;161(5):1608–13. DOI 10.1164/ajrccm.161.5.9908022.

(17) Sachs AP, Koeter GH, Groenier KH, van der Waaij D, Schiphuis J, Meyboom-de Jong B. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax. 1995;50(7):758-63. DOI 10.1136/thx.50.7.758.

(18) Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999;354(9177):456–60. DOI 10.1016/S0140-6736(98)11326-0.

(19) Parker CM, Voduc N, Aaron SD, Webb KA, O’Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur Respir J. 2005;26(3):420–8. DOI 10.1183/09031936.05.00136304.

(20) Johnson MK, Birch M, Carter R, Kinsella J, Stevenson RD. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax. 2007;62(4):299–306. DOI 10.1136/thx.2006.061044.

(21) Donaldson GC, Law M, Kowlessar B, Singh R, Brill SE, Allinson JP et al. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2015;192(8):943-50. DOI 10.1164/rccm.201412-2269OC.

(22) Rea H, Kenealy T, Adair J, Robinson E, Sheridan N. Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis. 2011;6:527–32. DOI 10.2147/COPD.S24133.

(23) Loh CH, Genese FA, Kannan KK, Lovings TM, Peters SP, Ohar JA. Spirometry in hospitalized patients with acute exacerbation of COPD accurately predicts post discharge airflow obstruction. Chronic Obstr Pulm Dis. 2018;5(2):124-33. DOI 10.15326/jcopdf.5.2.2017.0169.

(24) Fernández-Villar A, Represas-Represas C, Mouronte-Roibás C, Ramos-Hernández C, Priegue-Carrera A, Fernández-García S et al. Reliability and usefulness of spirometry performed during admission for COPD exacerbation. PLoS One. 2018;13(3):1-12. DOI 10.1371/journal.pone.0194983.

(25) Spero K, Bayasi G, Beaudry L, Barber KR, Khorfan F. Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2417-23.